Cytokines and chemokines in HIV infection: Implications for therapy

International Reviews of Immunology

Volumn 16, Issue 5-6, 1998, Pages 705-726

  Emilie, Dominique ^a   Galanaud, Pierre ^a  

^a INSERM   (France)

Author keywords

Chemokines; Cytokines; HIV

Indexed keywords

EID: 0031803992     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189809043015     Document Type: Article

References (89)

1. Aukrust, P., Liabakk, N.B., Muller, F., Lien, E., Espevik, T. and Froland, S.F. Serum levels of tumor necrosis factor-a and soluble TNF receptors in human immunodeficiency virus type 1 infection. Correlations to clinical, immunologic, and virologic parameters. J. Inf. Dis. 169 (1994) 420-424.
2. Birx, D.L., Redfield, R.R., Tencer, K., Fowler, A., Burke, D.S. and Tosato, G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 76 (1990) 2303-2310.
3. Breen, E.C., Rezal, A.R., Nakajima, K., Beall, G.N., Mitsuyasu, R.T., Hirano, T., Kishimoto, T. and Martinez-Maza, O. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 144 (1990) 480-484.
4. Weiss, L., Haeffner-Cavaillon, N., Laude, M., Gilquin, J. and Kazatchkine, M.D. HIV infection is associated with the spontaneous production of interleukin-1 in vivo and with an abnormal release of IL-1a in vitro. AIDS 3 (1989) 695-699.
5. Emilie, D., Peuchmaur, M., Maillot, M.-C., Crevon, M.-C., Brousse, N., Delfraissy, J.-F., Dormont, J. and Galanaud, P. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J. Clin. Invest. 86 (1990) 148-159.
6. Graziosi, C., Pantaleo, G., Gantt, K.R., Fortin, J.P., Demarest, J.F., Cohen, O.J., Sékali, R.P. and Fauci, A.S. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected patients. Science 265 (1994) 248-252.
7. Westendorp, M.O., Shatrov, V.A., Schulze-Osthoff, K., Frank, R., Kraft, M., Los, M., Krammer, P.H., Dröge, W. and Lehman, V. HIV-1 Tat potentiates TNF-induced NF-kB activation and cytotoxicity by altering the cellular redox state. EMBO J. 14 (1995) 546-554.
8. Borghi, P., Fantuzzi, L., Varano, B., Gessani, S., Puddu, P., Conti, L., Rosaria, M., Capobianchi, M.R., Ameglio, F. and Belardelli, F. Induction of Interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J. Virol. 69 (1995) 1284-1287.
9. Akridge, R.E., Oyafuso, L.K.M. and Reed, S.G. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153 (1994) 5782-5789.
10. Masood, R., Lunardi-Iskandar, Y., Moudgil, T., Zhang, Y., Law, R.E., Huang, C.L., Puri, R.K., Levine, A.M. and Gill, P.S. IL-10 inhibits HIV-1 replication and is induced by tat. Biochem. Biophys. Res. Commun. 202 (1994) 374-383.
11. Ameglio, F., Capobianchi, M R., Castilleti, C., Cordiali-Fei, P., Fais, S., Trento, E. and Dianzani, F. Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells. Correlation with the induction of other cytokines. Clin. Exp. Immunol. 95 (1994) 455-458.
12. Emilie, D., Fior, R., Llorente, L., Marfaing-Koka, A., Peuchmaur, M., Devergne, O., Jarrousse, B., Wijdenes, J., Boue, F. and Galanaud, P. Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease and in the development of B lymphomas. Immunol. Rev. 140 (1994) 5-34.
13. Emilie, D., Fior, R., Crevon, M.C., Maillot, M.C., Boue, F. and Galanaud, P. Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease. Res. Immunol. 145 (1995) 595-604.
14. Denis, M. and Ghadirian, E. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res. Hum. Retroviruses 10 (1994) 1619-1627.
15. Gallo, P., Sivieri, S., Rinaldi, L., Yan, X.B., Lolli, F., De Rossi, A. and Tavolato, B. Intrathecal synthesis of interleukin 10 in viral and inflammatory diseases of the central nervous system. J. Neurol. Sci. 126 (1994) 49-53.
16. Rimaniol, A.C., Boussin, F., Herbelin, A., De Groote, D., Dormont, D., Bach, J.F., Descamps-Latscha, B. and Zavala, F. Induction of soluble tumor necrosis factor receptor (sRNF-R75) release by HIV adsorption on cultured human monocytes. Eur. J. Immunol. 24 (1994) 2055-2060.
17. Godfried, M.H., Van der Poll, T., Weverling, G.J., Mulder, J.W., Jansen, J., Van Deventer, S.J.H. and Sauerwein, H.P. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J. Infect. Dis. 169 (1994) 739-745.
18. Frissen Jos, P.H., Weverling, G.J., Endert, E., Jansen, J., Sauerwein, H.P. and Lange, J. Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection. J AIDS 12 (1996) 482-488.
19. Billelo, J.A., Stellrecht, K., Drusano, G.L. and Stein, D.S. Soluble tumor necrosis factor-α receptor type II (sTNTFαRII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-Infected patients. J. Inf. Dis. 173 (1996) 464-467.
20. Chehimi, J., Starr, S.E., Frank, I., D'Andrea, A., Ma, X., MacGregor, R.R., Sennelier, J. and Trinchieri, G. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179 (1994) 1361-1366.
21. Harrison, T.S. and Levitz, S.M. Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection. J. Immunol. 156 (1996) 4492-4497.
22. Chougnet, C., Wynn, T.A., Clerici, M., Landay, A.L., Kessler, H.A., Rusnak, J., Melcher, G.P., Sher, A. and Shearer, G.M. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J. Inf. Dis. 174 (1996) 46-53.
23. Lane, H.C., Depper, J.M., Greene, W.C., Whalen, G., Waldmann, T.A. and Fauci, A.S. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 313 (1985) 79-84.
24. Clerici, M., Hakim, F.T., Venzon, D.J., Blatt, S., Hendrix, C.W., Wynn, T.A. and Shearer, G.M. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91 (1993) 759-765.
25. Meyaard, L., Schuitemaker, H. and Miedema, F. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function? Immunol. Today 14 (1993) 161-164.
26. Cefai, D., Debre, P., Kaczorek, M., Idziorek, T., Autran, B. and Bismuth, G. HIV-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. J. Clin. Invest. 86 (1990) 2117-2124.
27. Hivroz, C., Mazerolles, F., Sola, M., Fagard, R., Graton, S., Meloche, S., Sékaly, R. and Fischer, A. HIV gp120 and derived peptidesactivate protein tyrosine kinase p561ck in human CD4 T lymphocytes. Eur. J. Immunol. 23 (1993) 600-607.
28. Kovacs, J.A., Baseler, M., Dewar, R.J., Vogel, S., Davey, R.T., Falloon, J., Polis, M.A., Walker, R.E., Stevens, R., Salzman, N.P., Metcalf, J.A., Masur, H. and Lane, H.C. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. N. Engl. Med. 332 (1995) 567-575.
29. Teppler, H., Kaplan, G., Smith, K., Cameron, P., Montana, A., Meyn, P. and Conn, Z. Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection. J. Infect. Dis. 167 (1993) 291-298.
30. Teppler, H., Kaplan, G., Smith, K.A., Montana, A.L., Meyn, P. and Conn, Z.A. Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J. Exp. Med. 177 (1993) 483-492.
31. Kovacs, J.A., Vogel, S., Albert, J.M., Falloon, J., Davey, R.T., Walker, R.E., Polis, M.A., Spooner, K., Metcalf, J.A., Baseler, M., Fyfe, G. and Lane, H.C. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 335 (1996) 1350-1356.
32. Jacobson, E.L., Pilaro, F. and Smith, K.A. Rational interleukin 2 therapy for HIV positive individuals: Daily low doses enhance immune function without toxicity. Proc. Natl. Acad. Sci. USA 93 (1996) 10405-10410.
33. Clerici, M. and Shearer, G.M. A Th1→Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14 (1993) 107-110.
34. Boyle, M.J., Berger, M.F., Tschucnigg, M., Valentine, J.E., Kennedy, B.G., Divjak, M., Cooper, D.A., Turner, J.J., Penny, R. and Sewell, W.A. Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients. Clin. Exp. Immunol. 92 (1993) 100-105.
35. Llorente, L., Richaud-Patin, Y., Fior, R., Alcocer-Varela, J., Wijdenes, J., Morel Fourrier, B., Galanaud, P. and Emilie, D. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis. Rheum. 37 (1994) 1647-1655.
36. Romagnani, S., Del Prete, G., Manetti, R., Ravina, A., Annunziato, F., De Carli, M., Mazzetti, M., Piccinni, M.P., D'Elios, M.M., Parronchi, P., Sampognaro, S. and Maggi, E. Role of Th1/Th2 cytokines in HIV infection. Immunol. Rev. 140 (1994) 73-92.
37. Zou, W., Dulioust, A., Fior, R., Durand-Gasselin, I., Boué, F., Galanaud, P. and Emilie, D. Increased Th2-type cytokine production in chronic HIV infection is due to IL-13 rather than IL-4. AIDS 11 (1997) 533-534.
38. Meyaard, L., Hovenkamp, E., Keet, I., Hooibrink, B., De Jong, I., Otto, S.A. and Miedema, F. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals. J. Immunol. 157 (1996) 2712-2718.
39. Zou, W., Lackner, A.A., Simon, M., Durand-Gasselin, I., Galanaud, P., Desrosiers, R.C. and Emilie, D. Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J. Virol. 71 (1997) 1227-1236.
40. Zou, W., Coulomb, A., Venet, A., Foussat, A., Berrebi, D., Beyer, C., Crevon, M.C., Minty, A., Couedel-Courteille, A., Vivier, E., Capron, F., Galanaud, P. and Emilie, D. Administration of IL-13 to SIV-infected macaques induction of intestinal epithelium atrophy. Submitted for publication.
41. Chehimi, J., Starr, S.E., Frank, I., Rengaraju, M., Jackson, S.J., Lianes, C., Kobayashi, M., Perussia, B., Young, D., Nickbarg, E., Wolff, S.F. and Trinchieri, G. NK cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and HIV-infected patients. J. Exp. Med. 175 (1992) 789-796.
42. Clerici, M., Lucey, D., Berzofsky, J., Pinto, L.A., Wynn, T.A., Blatt, S.P., Dolan, M.J., Hendrix, C.W., Wolf, S.F. and Shearer, G.M. Restoration of HIV-specific cell-mediated immune responses by interleukin 12 in vitro. Science 262 (1993) 1721-1724.
43. Uherova, P., Connick, E., Whinney, S.M., Schlichtemeier, R., Schooley, R.T. and Kuritzkes, D.R. In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1. J. Inf. Dis. 174 (1996) 483-489.
44. (44] Landay, A.L., Clerici, M., Hashemi, F., Kessler, H., Berzofsky, J.A. and Shearer, G.M. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of Interleukin (IL)-12 and Anti-IL-10. J. Inf. Dis. 173 (1996) 1085-1091.
45. Blauvelt, A., Chougnet, C., Shearer, G.M. and Katz, S.I. Modulation of T cell responses to recall antigens presented by langerhans cells in HIV-discordant identical twins by anti-Interleukin (IL)-10 antibodies and IL-12. J. Clin. Invest. 6 (1996) 1550-1555.
46. Cierici, M., Wynn, T.A., Berzofsky, J.A., Blatt, S.P., Hendrix, C.W., Sher, A., Coffman, R.L. and Shearer, G.M. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with HIV. J. Clin. Invest 93 (1994) 768-777.
47. Zhang, M., Gong, J., Lyer, D.V., Jones, B.E., Modlin, R.L. and Barnes, P.F. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J. Clin. Invest. 94 (1994) 2435-2442.
48. Blatt, S.P., Hendrix, C.W., Butzin, C.A., Freeman, T.M., Ward, W.W., Hensley, R.E., Melcher, G.P., Donovan, D.J. and Boswell, R.N. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann. Intern. Med. 119 (1993) 177-183.
49. Lucey, D.R., Melcher, G.P., Hendrix, C.W., Zajac, R.A., Goetz, D.W., Butzin, C.A., Clerici, M., Warner, R.D., Abbadessa, S. and Hall, K. The US air force HIV study 1985-1990: immunological analyses, seroconversion and the potential utility of a T-helper functional assay to predict change in CD4+ T-cell counts during early stage HIV infection. J. Inf. Dis. 164 (1991) 631-637.
50. Cierici, M., Balotta, C., Salvaggio, A., Riva, C., Trabattoni, D., Papagno, L., Berlusconi, A., Rusconi, S., Villa, M.L., Moroni, M. and Galli, M. Human Immunodeficiency Virus (HIV) phenotype and Interleukin-2/Interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 88 (1996) 574-579.
51. Schuitemakern, H., Meyaard, L., Koostra, N.A., Dubbes, R., Otto, S.A., Tersmette, M., Heeney, J.L. and Miedema, F. Lack of T cell dysfunction and programmed cell death in HIV type-1-infected chimpanzees correlates with absence of monocytotropic variants. J. Inf. Dis. 168 (1993) 1140-1147.
52. Mosier, D.E., Gulizia, R.J., MacIsaac, P.D., Torbett, B.E. and Levy, J.A. Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science 260 (1993) 689-692.
53. Ho, D.D., Neuman, A.U., Perelson, A.S., Chen, W., Leonard, J.M. and Markowitz, M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (1995) 12-126.
54. Cierici, M., Sarin, A., Coffman, R.L., Wynn, T.A., Blatt, S.P., Hendrix, C.W., Wolf, S.F., Shearer, G.M. and Henkart, P.A. Type 1/type 2 cytokine modulation of T-cell programed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci USA 91 (1994) 11811-11815.
55. Estaquier, J., Idziorek, T., Zou, W., Emilie, D., Farber, C.M., Bourez, J.M. and Ameisen, J.C. TH1/TH2 cytokines and T-cell death: preventive effect of IL-12 on activation induced and CD95 (FAS/APO-1) mediated apoptosis of CD4+ T cells from HIV-infected persons. J. Exp. Med. 182 (1995) 1759-1767.
56. Maggi, E., Giudizi, M.G., Biagiotti, R., Annunziato, F., Manetti, R., Piccinni, M.P., Parronchi, P., Sampognaro, S., Giannarini, L., Zuccati, G. and Romagnani, S. Th2-like CD8+ T-cells showing B cell helper function and reduced cytolytic activity in HIV type 1 infection, J. Exp. Med. 180 (1994) 489-495.
57. Marfaing-Koka, A., Aubin, J.T., Grangeot-Keros, L., Portier, A., Benattar, C., Merrien, D., Agut, H., Aucouturier, P., Autran, B., Wijdenes, J., Galanaud, P. and Emilie, D. (1995) In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients. J. AIDS Hum. Retrovirol. 11 (1996) 59-68.
58. Agosti, J.M., Coombs, R.W., Collier, A.C., Paradise, M.A., Benedetti, J.K., Jaffe, H.S. and Corey, L. A randomized, double-blind, phase I/II trial of tumor necrosis factor and interferon-gamma for treatment of AIDS-related complex (Protocol 025 from the AIDS clinical trials group). AIDS Res. Hum. Retroviruses 8 (1992) 581-587.
59. Levine, J.D., Allan, J.D., Tessitore, J.H., Falcone, N., Galasso, F., Israel, R.J. and Groopman, J.E. Recombinant human granulocyte-macrophage colony stimulating factor ameliorates Zidovudine induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS related complex. Blood 78 (1991) 3148-3154.
60. Walker, R.E., Spooner, K.M., Kelly, G., McCloskey, R.V., Woody, J.N., Falloon, J., Baseler, M., Piscitelli, S.C., Davey, R.T., Polis, M.A., Kovacs, J.A., Masur, H. and Lane, C. Inhibition of imrminoreactive tumor necrosis factor-α by a chimeric antibody in patients infected with human immunodeficiency virus type 1. J. Inf. Dis. 174 (1996) 63-68.
61. Lane, H.C. Interferons in HIV and related diseases. AIDS 8 (1994) S19-S23.
62. Mackewicz, C.E., Blackbourn, D.J. and Levy, J.A. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA 92 (1995) 2308-2312.
63. Kinter, A.L., Bende, S.M., Hardy, E.C., Jackson, R. and Fauci, A.S. Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression. Proc. Natl. Acad. Sci. USA 92 (1995) 10985-10989.
64. Barker, E., Machewicz, C.E. and Levy, J.A. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: Implications for long-term survival. Proc. Natl. Acad. Sci. USA 92 (1995) 11135-11139.
65. Baier, M., Werner, A., Bannert, N., Metzner, K. and Kurth, R. HIV suppression by interleukin-6. Nature 378 (1995) 563-564.
66. Center, D.M., Kornfeld, H. and Cruikshank, W.W. Interleukin 16 and its function as a CD4 Iigand. Immunol. Today 10 (1996) 476-481.
67. Mackewitz, C.E., Levy, J.A., Cruikshank, W.W., Kornfeld, H. and Center, D.M. Role of IL-16 in HIV replication. Nature 383 (1996) 488-489.
68. Feng, Y., Broder, C.C., Kennedy, P.E. and Berger, E.A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 (1996) 872-874.
69. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J.M., Arenzana-Seisdedos, F., Schwartz, O., Heard, J.M., Clark-Lewis, I., Legler, D.F., Loetscher, M., Baggiolini, M. and Moser, B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382 (1996) 833-835.
70. Bleul, C.C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. and Springer, T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/ fusion and blocks HIV-1 entry. Nature 382 (1996) 829-832.
71. Cocchi, F., DeVico, A.L., Garzino-Demo, A., Arya, S.K., Gallo, R.C. and Lusso, P. Identification of RANTES, MIP-1 α and MIP-1 β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270 (1995) 1811-1815.
72. Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Kennedy, P.E., Murphy, P.M. and Berger, E.A. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272 (1996) 1955-1958.
73. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D., Wu, L., Mackay, C.R., La Rosa, G., Newman, W., Gerard, N., Gerard, C. and Sodroski, J. The β-Chemokine Receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85 (1996) 1135-1148.
74. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R.E., Hill, C.M., Davis, C.B., Peiper, S.C., Schall, T.J., Littman, D.R. and Landau, N.R. Identification of a major coreceptor for primary isolates of HIV-1. Nature 381 (1996) 661-666.
75. Drajic, T., Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y., Nagashima, K.A., Cayanan, C., Maddon, P.J., Koup, R.A., Moore, JLP. and Paxton, W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381 (1996) 667-673.
76. Doranz, B.J., Rucker, J., Yi, Y., Smyth, R.J., Samson, M., Peiper, S.C., Parmentier, M., Collman, R.G. and Doms, R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85 (1996) 1149-1158.
77. Rucker, J., Samson, M., Doranz, B.J., Libert, F., Berson, J.F., Yi, Y., Smyth, R.J., Collman, R.G., Broder, C.C., Vassart, G., Doms, R.W. and Parmentier, M. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87 (1996) 437-446.
78. Zhang, L., Huang, Y., He, T., Cao, Y. and Ho, D.D. HIV-1 subtype and second-receptor use. Nature 383 (1996) 768.
79. Oravecz, T., Pall, M. and Norcross, M.A. β-Chemokine Inhibition of Monocytotropic HIV-1 Infection. J. Imtnunol, 157 (1996) 1329-1332.
80. Levy, J.A. Infection by human immunodeficiency virus CD4 is not enough. N. Engl. J. Med. 14 (1996) 1528-1530.
81. Endres, M.J., Clapham, P.R., Marsh, M., Ahuja, M., Turner, J.D., Mcknight, A., Thomas, J.F., Stoebenauhaggarty, B., Choe, S., Vance, P.J., Wells, T.N.C., Power, C.A., Sutterwala, S.S., Doms, R.W., Landau, N.R. and Hoxie, J.A. CD4-independent infection by HIV-2 is mediated by fusin-CXCR4. Cell 87 (1996) 745-756.
82. Canque, B.B., Rosenzwajg, M., Gey, A., Tartour, E., Fridman, W.H. and Gluckman, J.C. Macrophage inflammatory protein-1α is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood 87 (1996) 2011-2019.
83. Schmidtmayerova, H., Nottet, H., Nuovo, G., Raabe, T., Flanagan, C.R., Dubrovsky, L., Gendelman, H.E., Cerami, A., Bukrinsky, M. and Sherry, B. Human immunodeficiency virus type 1 infection alters chemokine β peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 93 (1996) 700-704.
84. Schmidtmayerova, H., Sherry, B. and Bukinsky, M. Chemokines and HIV replication. Nature 382 (1996) 767.
85. Arenzana-Seisdedos, F., Virelizier, J.-L., Rousset, D., Clark-Lewis, I., Loetscher, P., Moser, B., Baggiolini, M. HIV blocked by chemokine antagonist. Nature 383 (1996) 400.
86. Paxton, W.A., Martin, S.R., Tse, D., O'Brien, T.R., Skurnick, J., Van Devanter, N.L., Padian, N., Braun, J.F., Kotler, D.P., Wolinsky, S.M. and Koup, R.A. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Medicine 4 (1996) 412-417.
87. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., Mac Donald, M.E., Stuhlmann, H., Koup, R.A. and Landau, N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 (1996) 367-377.
88. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Leisnard, C., Farber, C.M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R.J., Collman, R.G., Doms, R.W., Vassart, G. and Parmentier, M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 (1996) 722-725.
89. Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W., Allikmets, R., Goedert, J.J., Buchbinder, S.P., Vittinghoff, E., Gomperts, E., Donfiels, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C. and Detels, R. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273 (1996) 1856-1862.